SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
1-Year Return
0.41%
This Quarter Return
-0.98%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$1.01B
AUM Growth
-$92.9M
(-8.4%)
Cap. Flow
+$4.34M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
43.14%
Holding
161
New
32
Increased
25
Reduced
24
Closed
46
Top Buys
| 1 |
Pfizer
PFE
|
$47.6M |
| 2 |
Eli Lilly
LLY
|
$38.5M |
| 3 |
AbbVie
ABBV
|
$24.8M |
| 4 |
Palo Alto Networks
PANW
|
$14.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$11.5M |
Top Sells
| 1 |
Merck
MRK
|
$60.1M |
| 2 |
Johnson & Johnson
JNJ
|
$26.9M |
| 3 |
LivePerson
LPSN
|
$14.2M |
| 4 |
Generac Holdings
GNRC
|
$13.6M |
| 5 |
Amazon
AMZN
|
$12.8M |
Sector Composition
| 1 | Healthcare | 74.46% |
| 2 | Technology | 12.76% |
| 3 | Industrials | 4.7% |
| 4 | Financials | 3.69% |
| 5 | Communication Services | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZEN
51
DELISTED
ZENDESK INC
ZEN
| $6.28M | 0.53% |
+53,910
| New | +$6.28M |
|
|
RACB
52
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $5.91M | 0.5% |
600,000
| – | – |
|
53
Xenon Pharmaceuticals
XENE
$3.02B
| $5.71M | 0.48% |
373,510
+97,380
| +35% | +$1.49M |
|
|
PNT
54
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $5.68M | 0.48% |
739,190
-270,307
| -27% | -$2.08M |
|
55
PMV Pharmaceuticals
PMVP
$77.4M
| $5.68M | 0.48% |
190,525
+106,451
| +127% | +$3.17M |
|
56
Sutro Biopharma
STRO
$89.9M
| $5.57M | 0.47% |
294,825
| – | – |
|
57
uniQure
QURE
$985M
| $5.51M | 0.46% |
172,000
| – | – |
|
58
Calix
CALX
$3.96B
| $5.2M | 0.44% |
+105,290
| New | +$5.2M |
|
59
Allot
ALLT
$390M
| $5.07M | 0.43% |
341,067
+64,880
| +23% | +$964K |
|
60
Nautilus Biotechnolgy
NAUT
$83.5M
| $4.91M | 0.41% |
800,000
| – | – |
|
61
Caribou Biosciences
CRBU
$174M
| $4.77M | 0.4% |
+200,000
| New | +$4.77M |
|
62
Amicus Therapeutics
FOLD
$2.46B
| $4.69M | 0.39% |
+491,159
| New | +$4.69M |
|
63
Protagonist Therapeutics
PTGX
$3.77B
| $4.61M | 0.39% |
260,379
-42,586
| -14% | -$755K |
|
|
VRNA
64
Verona Pharma
VRNA
$9.2B
| $4.39M | 0.37% |
801,256
| – | – |
|
|
IS
65
DELISTED
ironSource Ltd.
IS
| $3.99M | 0.34% |
+367,070
| New | +$3.99M |
|
66
Aligos Therapeutics
ALGS
$78.8M
| $3.87M | 0.32% |
+9,968
| New | +$3.87M |
|
67
Dynavax Technologies
DVAX
$1.18B
| $3.82M | 0.32% |
+198,880
| New | +$3.82M |
|
68
ESSA Pharma
EPIX
$11M
| $3.76M | 0.32% |
469,402
-178,901
| -28% | -$1.43M |
|
69
Dyne Therapeutics
DYN
$2.02B
| $3.66M | 0.31% |
225,083
-144,631
| -39% | -$2.35M |
|
70
Immunic
IMUX
$75.1M
| $3.45M | 0.29% |
+389,812
| New | +$3.45M |
|
|
EUCR
71
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
| $3.22M | 0.27% |
329,025
| – | – |
|
72
Intellia Therapeutics
NTLA
$1.29B
| $3.17M | 0.27% |
23,647
-28,903
| -55% | -$3.88M |
|
73
Leslie's
LESL
$64.6M
| $3.08M | 0.26% |
+150,000
| New | +$3.08M |
|
|
OTMO
74
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
| $2.87M | 0.24% |
+40,000
| New | +$2.87M |
|
75
argenx
ARGX
$45.9B
| $2.79M | 0.23% |
9,249
| – | – |
|